70 likes | 75 Views
Meperidine belongs to a class of drugs known as opioids, and is an analgesic similar to morphine. Meperidine was originally approved in 1942. Meperidine is available in different dosage forms such as tablets, syrup, oral solution, and injectable solutions. Meperidine is indicated for the management of severe pain which cannot be controlled by alternative treatments due to which opioid medication becomes necessary. Meperidine is legally available under the Controlled Substance Act (CSA) and under the drug class - schedule II drug in the U.S. The substances wh
E N D
Meperidine (Demerol) Market Analysis https://www.coherentmarketinsights.com
Table of Contents Research Objectives and Assumptions Market Overview Market Dynamics, Regulations, and Trends Analysis Global Meperidine (Demerol) Market – Impact of Coronavirus (Covid – 19) Pandemic Global Meperidine (Demerol) Market, By Dosage Form, 2016 - 2027 (US$ Million) Global Meperidine (Demerol) Market, By Distribution Channel, 2016 - 2027 (US$ Million) Global Meperidine (Demerol) Market, By Region, 2016 - 2027 (US$ Million) Competitive Landscape Section https://www.coherentmarketinsights.com
Report Highlights • The meperidine is also known as pethidine. It is a synthetic opioid analgesic and used in pain management. It is also used to treat rigors and in post anesthesia-shivers. Several physicians prefer to prescribe meperidine for the treatment of acute and chronic severe pain as it has lesser risk of addiction and is safer than morphine. • Prominent Regions- • Latin America • North America • Middle East • Europe • Asia Pacific • Africa https://www.coherentmarketinsights.com
Report Highlights • The global meperidine (Demerol) market is estimated to be valued at US$ 2,089.1 Mn in 2020 and is expected to increase to US$ 2,784.3 Mn by 2027, witnessing a CAGR of 4.2% during the forecast period (2020-2027).. • Key players operating in the global meperidine (Demerol) market include Pfizer, Inc., Hikma Pharmaceuticals USA Inc., Epic Pharma, Inc., and Vintage Pharmaceuticals, Inc. https://www.coherentmarketinsights.com
Report Highlights • Restraints & Challenges- • Factors such as increasing drug/opioid addiction, presence of alternative opioid medications • Loss of consciousness • Growth Drivers- • The increasing number of surgical procedures • The rising prevalence of conditions such as cancer and other pain related diseases https://www.coherentmarketinsights.com
Report Links • View Full Report of Meperidine (Demerol) Market Analysis • Request For Sample Copy For Meperidine (Demerol) Market Analysis • Download PDF Brochure For Meperidine (Demerol) Market Analysis
About coherentmarketinsights.com • Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. • We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. Our global team of over 100 research analysts and freelance consultants provide market intelligence from the very molecular country level and also provide a global perspective of the market. • Sales-sales@coherentmarketinsights.com • Email-https://www.coherentmarketinsights.com